As pharmaceutical manufacturers move towards small batch production, process flexibility is increasingly critical to minimize changeover times and maintain – or increase – profitability. Two factors continue to drive the rising demand for process flexibility. One is biopharmaceutical manufacturers’ focus on developing novel therapeutics
MoreAs pharmaceutical manufacturers move towards small batch production, process flexibility is increasingly critical to minimize changeover times and maintain –
MoreOn food and pharmaceutical production lines, as elsewhere in life, the smallest expenses can soon add up into something insurmountable.
More[wp_ad_camp_4]Frankfurt/Main, Germany – At Achema, Bosch Packaging Technology showcases its latest version of the rotary pen assembly machine MRA. Developed
MoreA biologic medicine is a large molecule typically derived from living cells and used in the treatment, diagnosis or prevention
More